DEA to the Fourth Circuit: Nobody Has Standing to Fight the HHC Listing
Two hemp companies are challenging the DEA's Schedule I drug code for HHC. The agency leads with standing: the rule, it says, was too inconsequential for anyone to be injured by it — which is also the answer to where HHC stands today.